Profil
Daniel P.
Gold is the founder of MMRGlobal, Inc. (founded in 2000) and Favrille, Inc. (founded in 2000).
At MMRGlobal, Inc. and Favrille, Inc., he held various titles.
Currently, he is a Trustee at The Hope Funds for Cancer Research.
Previously, he was the President & Chief Executive Officer at Prospect Therapeutics, Inc. (2008-2009), a Director at MEI Pharma, Inc. (2010-2023), a Managing Partner at Theragence, Inc. (2009-2010), and an Associate Professor at Sidney Kimmel Cancer Center (1992-2003).
He received his undergraduate degree from the University of California, Los Angeles and his doctorate from Tufts University.
Aktiva positioner av Daniel Gold
| Företag | Position | Start |
|---|---|---|
The Hope Funds for Cancer Research
The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services Provides funds for cancer research | Direktör/Styrelseledamot | 2011-10-21 |
Tidigare kända positioner av Daniel Gold
| Företag | Position | Slut |
|---|---|---|
| LITE STRATEGY, INC. | Verkställande Direktör | 2011-04-15 |
Theragence, Inc.
Theragence, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparations | Företagsledare/Principal | 2010-04-01 |
Favrille, Inc.
Favrille, Inc. Medical SpecialtiesHealth Technology Researches, develops and commercializes targeted immunotherapies for the treatment of cancer and diseases of the immune system | Grundare | 2009-04-22 |
Prospect Therapeutics, Inc.
Prospect Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals to treat variety of cancers | Verkställande Direktör | 2009-05-01 |
Sidney Kimmel Cancer Center
Sidney Kimmel Cancer Center Medical/Nursing ServicesHealth Services Provides medical research services | Företagsledare/Principal | 2003-01-01 |
Daniel Golds utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Favrille, Inc.
Favrille, Inc. Medical SpecialtiesHealth Technology Researches, develops and commercializes targeted immunotherapies for the treatment of cancer and diseases of the immune system | Health Technology |
MEI Pharma, Inc.
MEI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sidney Kimmel Cancer Center
Sidney Kimmel Cancer Center Medical/Nursing ServicesHealth Services Provides medical research services | Health Services |
Prospect Therapeutics, Inc.
Prospect Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals to treat variety of cancers | Health Technology |
MMRGlobal, Inc.
MMRGlobal, Inc. Information Technology ServicesTechnology Services Provides electronic document management and online personal health record and storage solutions | Technology Services |
The Hope Funds for Cancer Research
The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services Provides funds for cancer research | Commercial Services |
Theragence, Inc.
Theragence, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparations | Health Technology |
















